India’s first CAR-T cell therapy, NexCAR19, is developed through collaboration between the IIT Bombay and Tata Memorial Hospital, in association with industry partner ImmunoACT, a start-up of two students Alka Dwivedi and Atharva Karulkar, and professor Rahul Purwar. TheHealthSite.com